A detailed history of Arkadios Wealth Advisors transactions in Viatris Inc stock. As of the latest transaction made, Arkadios Wealth Advisors holds 14,029 shares of VTRS stock, worth $182,377. This represents 0.01% of its overall portfolio holdings.

Number of Shares
14,029
Previous 82,600 83.02%
Holding current value
$182,377
Previous $878,000 81.55%
% of portfolio
0.01%
Previous 0.06%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 24, 2024

SELL
$10.32 - $12.13 $707,652 - $831,766
-68,571 Reduced 83.02%
14,029 $162,000
Q2 2024

Jul 29, 2024

BUY
$10.05 - $12.02 $1,427 - $1,706
142 Added 0.17%
82,600 $878,000
Q1 2024

Apr 30, 2024

SELL
$11.27 - $13.53 $50,940 - $61,155
-4,520 Reduced 5.2%
82,458 $984,000
Q4 2023

Jan 24, 2024

BUY
$8.77 - $10.85 $178,943 - $221,383
20,404 Added 30.65%
86,978 $941,000
Q3 2023

Oct 13, 2023

BUY
$9.59 - $11.35 $12,399 - $14,675
1,293 Added 1.98%
66,574 $656,000
Q2 2023

Jul 26, 2023

SELL
$9.02 - $10.29 $9,200 - $10,495
-1,020 Reduced 1.54%
65,281 $651,000
Q1 2023

May 02, 2023

BUY
$9.2 - $12.26 $609,969 - $812,850
66,301 New
66,301 $637,000
Q4 2021

Feb 03, 2022

SELL
$12.09 - $14.68 $39,884 - $48,429
-3,299 Closed
0 $0
Q3 2021

Oct 19, 2021

SELL
$13.25 - $15.13 $10,321 - $11,786
-779 Reduced 19.1%
3,299 $44,000
Q2 2021

Jul 28, 2021

BUY
$12.97 - $16.15 $25,096 - $31,250
1,935 Added 90.29%
4,078 $58,000
Q1 2021

Apr 26, 2021

BUY
$13.59 - $18.54 $11,374 - $15,517
837 Added 64.09%
2,143 $29,000
Q4 2020

Feb 09, 2021

BUY
$14.3 - $18.74 $18,675 - $24,474
1,306 New
1,306 $24,000

Others Institutions Holding VTRS

About Viatris Inc


  • Ticker VTRS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 1,212,669,952
  • Market Cap $15.8B
  • Description
  • Viatris Inc. operates as a healthcare company worldwide. The company operates in four segments: Developed Markets, Greater China, JANZ, and Emerging Markets. It offers prescription brand drugs, generic drugs, complex generic drugs, biosimilars, and active pharmaceutical ingredients (APIs). The company offers drugs in various therapeutic areas, i...
More about VTRS
Track This Portfolio

Track Arkadios Wealth Advisors Portfolio

Follow Arkadios Wealth Advisors and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Arkadios Wealth Advisors, based on Form 13F filings with the SEC.

News

Stay updated on Arkadios Wealth Advisors with notifications on news.